Maxim V. Cheine

642 total citations
8 papers, 447 citations indexed

About

Maxim V. Cheine is a scholar working on Psychiatry and Mental health, Philosophy and Pharmacology. According to data from OpenAlex, Maxim V. Cheine has authored 8 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 3 papers in Philosophy and 2 papers in Pharmacology. Recurrent topics in Maxim V. Cheine's work include Schizophrenia research and treatment (8 papers), Mental Health and Psychiatry (3 papers) and Treatment of Major Depression (2 papers). Maxim V. Cheine is often cited by papers focused on Schizophrenia research and treatment (8 papers), Mental Health and Psychiatry (3 papers) and Treatment of Major Depression (2 papers). Maxim V. Cheine collaborates with scholars based in Finland, India and United Kingdom. Maxim V. Cheine's co-authors include Kristian Wahlbeck, Adib Essali, Clive E Adams, Grigori Joffe, Katinka Tuisku, Antti Ahokas, Ranan Rimón, Efraim Shek, Simon Gilbody and J. Ahonen and has published in prestigious journals such as American Journal of Psychiatry, Cochrane Database of Systematic Reviews and Schizophrenia Bulletin.

In The Last Decade

Maxim V. Cheine

8 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxim V. Cheine Finland	7	384	134	97	64	38	8	447
A Breier United States	5	477 1.2×	142 1.1×	104 1.1×	93 1.5×	67 1.8×	8	555
J. Raniwalla United Kingdom	8	393 1.0×	84 0.6×	62 0.6×	109 1.7×	38 1.0×	19	427
Philippe Bouhours France	11	329 0.9×	88 0.7×	70 0.7×	131 2.0×	63 1.7×	20	481
Marc Eneman Belgium	5	235 0.6×	77 0.6×	73 0.8×	51 0.8×	37 1.0×	12	313
Lara McCartney Australia	5	402 1.0×	102 0.8×	76 0.8×	48 0.8×	40 1.1×	5	495
S. Heylen Belgium	7	452 1.2×	96 0.7×	94 1.0×	97 1.5×	92 2.4×	11	560
C.G.G. Link United Kingdom	8	500 1.3×	80 0.6×	79 0.8×	143 2.2×	75 2.0×	14	585
Michel Patris France	7	355 0.9×	85 0.6×	63 0.6×	190 3.0×	40 1.1×	15	425
Mark D. Watanabe United States	7	252 0.7×	66 0.5×	84 0.9×	60 0.9×	33 0.9×	11	414
B.G. Miller United States	7	620 1.6×	112 0.8×	123 1.3×	123 1.9×	67 1.8×	15	720

Countries citing papers authored by Maxim V. Cheine

Since Specialization

Citations

This map shows the geographic impact of Maxim V. Cheine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim V. Cheine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim V. Cheine more than expected).

Fields of papers citing papers by Maxim V. Cheine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim V. Cheine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim V. Cheine. The network helps show where Maxim V. Cheine may publish in the future.

Co-authorship network of co-authors of Maxim V. Cheine

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim V. Cheine. A scholar is included among the top collaborators of Maxim V. Cheine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim V. Cheine. Maxim V. Cheine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Shek, Efraim, et al.. (2010). Beta-Blocker Supplementation of Standard Drug Treatment for Schizophrenia. Schizophrenia Bulletin. 36(6). 1079–1080. 17 indexed citations

2.

Cheine, Maxim V., et al.. (2001). Beta-blocker supplementation of standard drug treatment for schizophrenia. Cochrane Database of Systematic Reviews. 2010(7). CD000234–CD000234. 11 indexed citations

3.

Wahlbeck, Kristian, Maxim V. Cheine, Katinka Tuisku, & Grigori Joffe. (2000). Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot trial. Schizophrenia Research. 41(1). 197–197. 3 indexed citations

4.

Wahlbeck, Kristian, et al.. (2000). Efficacy of β-blocker supplementation for schizophrenia: a systematic review of randomized trials. Schizophrenia Research. 41(2). 341–347. 11 indexed citations

5.

Wahlbeck, Kristian, Maxim V. Cheine, Katinka Tuisku, et al.. (2000). Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(6). 911–922. 56 indexed citations

6.

Cheine, Maxim V., et al.. (1999). Pharmacological treatment of schizophrenia resistant to first-line treatment: a critical systematic review and meta-analysis. International Journal of Psychiatry in Clinical Practice. 3(3). 159–169. 7 indexed citations

7.

Wahlbeck, Kristian, Maxim V. Cheine, Adib Essali, & Clive E Adams. (1999). Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials. American Journal of Psychiatry. 156(7). 990–999. 257 indexed citations

8.

Wahlbeck, Kristian, Maxim V. Cheine, & Adib Essali. (1999). Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database of Systematic Reviews. CD000059–CD000059. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact